Morten Herholdt
Stock Analyst at HSBC
(3.26)
# 2,454
Out of 5,032 analysts
39
Total ratings
62.1%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Sell | $157 → $175 | $222.89 | -21.49% | 8 | Sep 10, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $155 → $175 | $144.23 | +21.33% | 7 | Sep 10, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $290 → $320 | $254.78 | +25.60% | 10 | Sep 10, 2026 | |
| AMGN Amgen | Downgraded: Hold | $425 | $402.60 | +5.56% | 6 | Sep 9, 2026 | |
| ZTS Zoetis | Reiterated: Buy | $230 | $71.33 | n/a | 2 | Feb 19, 2024 | |
| UNH UnitedHealth Group | Downgraded: Sell | $540 → $480 | $376.32 | n/a | 2 | Dec 18, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiated Coverage: Buy | $12 | $1.11 | n/a | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiated Coverage: Buy | $260 | $259.98 | n/a | 1 | Sep 6, 2023 | |
| LH Labcorp Holdings | Initiated Coverage: Hold | $210 | $311.71 | n/a | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiated Coverage: Hold | $52 | $74.93 | n/a | 1 | Sep 6, 2023 |
Biogen
Sep 10, 2026
Reiterated: Sell
Price Target: $157 → $175
Current: $222.89
Upside: -21.49%
Gilead Sciences
Sep 10, 2026
Reiterated: Buy
Price Target: $155 → $175
Current: $144.23
Upside: +21.33%
Johnson & Johnson
Sep 10, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $254.78
Upside: +25.60%
Amgen
Sep 9, 2026
Downgraded: Hold
Price Target: $425
Current: $402.60
Upside: +5.56%
Zoetis
Feb 19, 2024
Reiterated: Buy
Price Target: $230
Current: $71.33
Upside: n/a
UnitedHealth Group
Dec 18, 2023
Downgraded: Sell
Price Target: $540 → $480
Current: $376.32
Upside: n/a
Actinium Pharmaceuticals
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $12
Current: $1.11
Upside: n/a
IQVIA Holdings
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $260
Current: $259.98
Upside: n/a
Labcorp Holdings
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $210
Current: $311.71
Upside: n/a
LivaNova
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $52
Current: $74.93
Upside: n/a